Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Mannkind Corporation (MNKD)

NASDAQ

$4.07

$+0.11

(+2.65%)

Regular Market

Mannkind Corporation (MNKD) Live Price Chart

Last updated: ⁦2026-09-04 15:47:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Mannkind Corporation (MNKD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.07, with a market capitalisation of $1.30B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.23 to $6.51. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.30B
Open	$4.01
Day's High	$121.55
Day's Low	$0.67
Previous Close	$3.96
Volume	849.83K
Average Volume	--
P/E Ratio	--
52-Week High	$6.51
52-Week Low	$2.23
Dividend Yield	--
Earnings Date	--

Mannkind Corporation (MNKD) Stock Price Today

Mannkind Corporation (MNKD) is currently trading at $4.07 as of 2026-09-04 15:30:55, up 2.65% ($0.11) from the previous close of $3.96

During today's regular trading session, MNKD has traded between $0.67 and $121.55, with a trading volume of 849.83K shares. The current price is near the lower end of today's range.

Mannkind Corporation (MNKD) 7-Day Stock Price Change

Over the past seven days, Mannkind Corporation (MNKD) moved from $3.94 to $4.07, representing a gain of 3.17% ($0.13).

The stock traded between $3.92 and $4.08 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 2.12 million shares, down versus the previous seven-day period, indicating lower trading activity.

MNKD 52-Week Price Position

Position in Range: 42.9%

52W Low$2.23

52W High$6.51

MNKD is currently trading at $4.07, placing it 42.9% of the way from its 52-week low of $2.23 to its 52-week high of $6.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Mannkind Corporation (MNKD)?

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Mannkind Corporation Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	592
Exchange	NASDAQ
Company Website	https://www.mannkindcorp.com

How to Buy Mannkind Corporation (MNKD) Stock on MEXC

Eligible investors can buy real shares of Mannkind Corporation (MNKD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MNKD and Place Your Order

Open the RealStocks trading page and search for MNKD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Mannkind Corporation (MNKD) stock price today?

Mannkind Corporation (MNKD) is currently trading at $ 4.07, up 2.65% ($0.11) from the previous close of $ 3.96. Intraday prices update in real time during regular trading hours.

2.Is MNKD stock going up or down today?

As of 2026-09-04 15:30:55, MNKD is trading at $ 4.07, up 2.65% ($0.11) from its previous close of $ 3.96. The stock has traded between $ 0.67 and $ 121.55 during today’s regular session. Past price movements do not guarantee future results.

3.What is MNKD pre-market price?

As of 2026-09-04 15:30:55, MNKD is trading at $ 3.95 in pre-market trading, down 0.23% ($0.01) from the previous close of $ 3.96. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MNKD after-hours price?

As of 2026-09-04 15:30:55, MNKD is trading at -- in after-hours trading, -- from the regular-session close of $ 3.96. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MNKD stock trading now?

MNKD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MNKD sit relative to its 52-week high and low?

Over the past 52 weeks, MNKD has traded between a low of $ 2.23 and a high of $ 6.51. At $ 4.07, the stock is positioned 42.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Mannkind Corporation in?

Mannkind Corporation (MNKD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Mannkind Corporation's market capitalisation and where is it listed?

Mannkind Corporation is listed on the NASDAQ exchange with a market capitalisation of $ 1.30B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MNKD valued in terms of P/E ratio and EPS?

MNKD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.14. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Mannkind Corporation pay a dividend?

Mannkind Corporation pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.